Acetylator phenotype, minimal maintenance dose and haemolytic effect of dapsone in dermatitis herpetiformis.
D000107:Acetylation; D000328:Adult; D000368:Aged; D003622:Dapsone / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D003874:Dermatitis Herpetiformis / Q000097:blood / Q000188:drug therapy* / Q000235:genetics; D004305:Dose-Response Relationship, Drug; D005260:Female; D006242:Haptoglobins / Q000032:analysis; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D013418:Sulfamethazine
D006242:Haptoglobins; D013418:Sulfamethazine; D003622:Dapsone